These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21961326)

  • 1. [Immunomodulating effects of macrolides: areas of possible clinical use in pulmonology].
    Sinopal'nikov AI
    Ter Arkh; 2011; 83(8):10-20. PubMed ID: 21961326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BTS guideline for the use of long-term macrolides.
    Congleton J
    Drug Ther Bull; 2021 May; 59(5):67-68. PubMed ID: 33753351
    [No Abstract]   [Full Text] [Related]  

  • 3. British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease.
    Smith D; Du Rand I; Addy CL; Collyns T; Hart SP; Mitchelmore PJ; Rahman NM; Saggu R
    Thorax; 2020 May; 75(5):370-404. PubMed ID: 32303621
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical basis of macrolides apply in diseases of the respiratory tract].
    Płusa T
    Pol Merkur Lekarski; 2008 Nov; 25(149):432-6. PubMed ID: 19177783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrolide antibiotics in the treatment of asthma. An update.
    Hernando-Sastre V
    Allergol Immunopathol (Madr); 2010; 38(2):92-8. PubMed ID: 20171003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term macrolide treatment of chronic inflammatory airway diseases: risks, benefits and future developments.
    Cameron EJ; McSharry C; Chaudhuri R; Farrow S; Thomson NC
    Clin Exp Allergy; 2012 Sep; 42(9):1302-12. PubMed ID: 22925316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrolides as immunomodulatory medications for the therapy of chronic lung diseases.
    López-Boado YS; Rubin BK
    Curr Opin Pharmacol; 2008 Jun; 8(3):286-91. PubMed ID: 18339582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory effects of macrolide antibiotics - part 2: advantages and disadvantages of long-term, low-dose macrolide therapy.
    Altenburg J; de Graaff CS; van der Werf TS; Boersma WG
    Respiration; 2011; 81(1):75-87. PubMed ID: 20733282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Macrolides. Antiinflammatory and immunomodulator effects. Indication in respiratory diseases].
    Sacre Hazouri JA
    Rev Alerg Mex; 2006; 53(3):108-22. PubMed ID: 16970113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrolides in the treatment of bronchiolitis obliterans in allograft recipients.
    Maimon N; Lipton JH; Chan CK; Marras TK
    Bone Marrow Transplant; 2009 Jul; 44(2):69-73. PubMed ID: 19430505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.
    Zarogoulidis P; Papanas N; Kioumis I; Chatzaki E; Maltezos E; Zarogoulidis K
    Eur J Clin Pharmacol; 2012 May; 68(5):479-503. PubMed ID: 22105373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrolide antibiotics as biological response modifiers.
    Rubin BK; Tamaoki J
    Curr Opin Investig Drugs; 2000 Oct; 1(2):169-72. PubMed ID: 11249569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
    Amsden GW
    J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators.
    Giamarellos-Bourboulis EJ
    Int J Antimicrob Agents; 2008 Jan; 31(1):12-20. PubMed ID: 17935949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BTS guideline on long-term macrolides in adults with respiratory disease: not quite a panacea.
    Smith D
    Thorax; 2020 May; 75(5):405-406. PubMed ID: 32303622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. British Thoracic Society guideline for the use of long-term macrolides in adults with respiratory disease.
    Smith D; Du Rand IA; Addy C; Collyns T; Hart S; Mitchelmore P; Rahman N; Saggu R
    BMJ Open Respir Res; 2020 Apr; 7(1):. PubMed ID: 32332022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrolides and airway inflammation in children.
    Shinkai M; Rubin BK
    Paediatr Respir Rev; 2005 Sep; 6(3):227-35. PubMed ID: 16153572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nonantibiotic properties of macrolides and their role in modulation of the inflammatory reaction].
    Zupanets IA; Tkachenko EM; Sakharova TS
    Eksp Klin Farmakol; 2012; 75(12):41-5. PubMed ID: 23700669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotics as immunomodulant agents in COPD.
    Blasi F; Mantero M; Aliberti S
    Curr Opin Pharmacol; 2012 Jun; 12(3):293-9. PubMed ID: 22321568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term macrolide therapy in chronic inflammatory airway diseases.
    Crosbie PA; Woodhead MA
    Eur Respir J; 2009 Jan; 33(1):171-81. PubMed ID: 19118228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.